MEDIFAST (MED) reported a severe financial downturn for Q3 and the Nine Months Ended September 30, 2025, driven entirely by contraction in its OPTAVIA coach network (down 35.0% to 19,500 active coaches). Management cited the rapid adoption of GLP-1 weight loss medications as a primary external headwind to client acquisition.
Financial Summary (Q3 vs Q3 2024): Revenue fell 36.2% to $89.4M. The company swung to a Net Loss of $(2.3M) (from $1.1M Income), resulting in a Diluted EPS loss of $(0.21) (vs. $0.10 profit). The primary driver of the quarterly and 9-month operating losses was Se
...